TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Huvudupphovsman: | Afroza, Halima |
---|---|
Övriga upphovsmän: | Talukder, Mesbah |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2024
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/22075 |
Liknande verk
-
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
av: Islam, Nahidul
Publicerad: (2023) -
Isolation and identification of α-amylase producing soil microorganisms and partial characterization of α-Amylase enzyme
av: Tamanna, Shams Tahsin
Publicerad: (2020) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
av: Islam, S.M. Zahidul
Publicerad: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
av: Khandker, Tahia Anjum
Publicerad: (2024) -
Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
av: Akter, Anika
Publicerad: (2022)